Cancer Immunotherapy with Nivolumab Plus Ipilimumab Vs. Chemotherapy: Insights from CheckMate 227
4 Pogledi
administrator
07/30/23
For more information, visit https://ascopubs.org/doi/full/10.1200/JCO.22.01503
Prikaži više
Komentari na Facebooku
Nema komentara